| 股號 / 名稱 | 總負債 | 淨值 |
| AZN AstraZeneca PLC | 64,203,000,000.0 | 40,719,000,000.0 |
| REGN 雷傑納榮製藥 | 8,116,000,000.0 | 29,325,900,000.0 |
| BNTX Biontech SE | 3,659,050,243.0 | 21,279,981,705.0 |
| GILD 吉利德科學 | 36,051,000,000.0 | 18,474,000,000.0 |
| BMY 施貴寶 | 76,528,000,000.0 | 17,142,000,000.0 |
| BIIB Biogen Inc | 11,954,300,000.0 | 16,358,900,000.0 |
| VRTX 福泰製藥 | 6,609,300,000.0 | 15,630,900,000.0 |
| MRNA 莫德納 | 3,876,000,000.0 | 11,927,000,000.0 |
| SVA Sinovac Biotech Ltd | 4,247,751,000.0 | 8,649,186,000.0 |
| AMGN 美國安進 | 83,356,000,000.0 | 7,527,000,000.0 |
| BIO.B Bio Rad Laboratories Inc | 3,115,613,000.0 | 7,487,859,000.0 |
| ABBV 艾伯維 | 137,390,000,000.0 | 6,032,000,000.0 |
| BMRN BioMarin Pharmaceutical Inc | 1,437,799,000.0 | 5,413,396,000.0 |
| ROIV Roivant Sciences Ltd | 1,053,073,000.0 | 5,152,955,000.0 |
| GMAB Genmab A/S | 1,156,134,580.0 | 4,769,466,020.0 |
| QGEN Qiagen NV | 2,740,203,000.0 | 3,529,994,000.0 |
| BGNE Beigene Ltd | 2,394,787,000.0 | 3,436,073,000.0 |
| PCVX Vaxcyte Inc | 142,112,000.0 | 3,417,634,000.0 |
| EXAS Exact Sciences Corp | 3,538,060,000.0 | 3,210,511,000.0 |
| GLPG Galapagos NV | 1,458,000,209.28 | 3,186,870,555.3 |
| INCY 英賽德 | 1,841,214,000.0 | 3,171,220,000.0 |
| EXEL Exelixis Inc | 684,857,000.0 | 2,275,419,000.0 |
| TECH Bio-Techne Corp | 597,367,000.0 | 2,138,650,000.0 |
| ILMN Illumina Inc | 3,889,000,000.0 | 2,125,000,000.0 |
| RGEN Repligen Corp | 813,958,000.0 | 2,016,686,000.0 |
| CRSP CRISPR Therapeutics AG | 316,472,000.0 | 1,939,658,000.0 |
| RNA Avidity Biosciences Inc | 137,391,000.0 | 1,503,380,000.0 |
| DNLI Denali Therapeutics Inc | 135,518,000.0 | 1,318,495,000.0 |
| ALKS Alkermes Plc | 863,185,000.0 | 1,292,106,000.0 |
| VIR Vir Biotechnology Inc | 257,629,000.0 | 1,240,727,000.0 |
| SRPT Sarepta Therapeutics Inc | 2,378,863,000.0 | 1,221,071,000.0 |
| IDYA IDEAYA Biosciences Inc | 59,455,000.0 | 1,180,418,000.0 |
| ITCI Intra-Cellular Therapies Inc | 179,619,000.0 | 1,144,826,000.0 |
| NUVL Nuvalent Inc | 67,732,000.0 | 1,121,126,000.0 |
| LEGN Legend Biotech Corp | 619,718,000.0 | 1,116,107,000.0 |
| ABCL Abcellera Biologics Inc | 314,734,000.0 | 1,078,094,000.0 |
| CERT Certara Inc | 489,824,000.0 | 1,053,405,000.0 |
| NTLA Intellia Therapeutics Inc | 210,736,000.0 | 962,615,000.0 |
| VKTX Viking Therapeutics Inc | 26,440,000.0 | 911,448,000.0 |
| NEO Neogenomics Inc | 732,901,000.0 | 908,210,000.0 |
| KYMR Kymera Therapeutics Inc | 141,912,000.0 | 892,930,000.0 |
| KRYS Krystal Biotech Inc | 96,472,000.0 | 885,846,000.0 |
| LGND Ligand Pharmaceuticals Inc | 113,688,000.0 | 841,178,000.0 |
| BCYC Bicycle Therapeutics PLC | 165,714,000.0 | 831,032,000.0 |
| CVAC CureVac NV | 144,163,261.97 | 806,795,696.55 |
| DNA Ginkgo Bioworks Holdings Inc | 682,940,000.0 | 797,943,000.0 |
| XENE Xenon Pharmaceuticals Inc | 38,094,000.0 | 797,807,000.0 |
| BEAM Beam Therapeutics Inc | 380,050,000.0 | 791,317,000.0 |
| CLDX Celldex Therapeutics Inc | 37,274,000.0 | 785,905,000.0 |
| IOVA Iovance Biotherapeutics Inc | 217,660,000.0 | 773,455,000.0 |
| HCM HUTCHMED (China) Ltd | 520,784,000.0 | 740,084,000.0 |
| AKRO Akero Therapeutics Inc | 79,222,000.0 | 738,325,000.0 |
| MYGN Myriad Genetics Inc | 349,600,000.0 | 731,700,000.0 |
| VRDN Viridian Therapeutics Inc | 64,404,000.0 | 707,496,000.0 |
| MRUS Merus NV | 141,415,000.0 | 703,261,000.0 |
| DVAX Dynavax Technologies Corp | 380,563,000.0 | 681,427,000.0 |
| ZLAB Zai Lab Ltd | 317,677,000.0 | 667,669,000.0 |
| JANX Janux Therapeutics Inc | 38,915,000.0 | 656,104,000.0 |
| ITOS Iteos Therapeutics Inc | 91,385,000.0 | 631,692,000.0 |
| CGEM Cullinan Therapeutics Inc | 25,392,000.0 | 627,862,000.0 |
| HRMY Harmony Biosciences Holdings Inc | 331,331,000.0 | 596,804,000.0 |
| ARVN Arvinas Inc | 581,100,000.0 | 586,000,000.0 |
| ACAD ACADIA Pharmaceuticals Inc | 399,688,000.0 | 577,180,000.0 |
| RCUS Arcus Biosciences Inc | 687,000,000.0 | 565,000,000.0 |
| DAWN Day One Biopharmaceuticals Inc | 45,344,000.0 | 555,463,000.0 |
| VNDA Vanda Pharmaceuticals Inc | 103,892,000.0 | 541,223,000.0 |
| PRTA Prothena Corporation PLC | 60,892,000.0 | 534,362,000.0 |
| KROS Keros Therapeutics Inc | 46,436,000.0 | 532,835,000.0 |
| SWTX SpringWorks Therapeutics Inc | 76,297,000.0 | 532,581,000.0 |
| PTGX Protagonist Therapeutics Inc | 71,942,000.0 | 531,915,000.0 |
| AMRN Amarin Corporation PLC | 219,240,000.0 | 531,375,000.0 |
| EBS Emergent BioSolutions Inc | 969,400,000.0 | 508,400,000.0 |
| NUVB Nuvation Bio Inc | 68,865,000.0 | 502,714,000.0 |
| EWTX Edgewise Therapeutics Inc | 22,405,000.0 | 488,877,000.0 |
| INSM Insmed Inc | 1,569,557,000.0 | 483,415,000.0 |
| ACLX Arcellx Inc | 281,891,000.0 | 483,018,000.0 |
| MESO Mesoblast Ltd | 188,798,000.0 | 480,355,000.0 |
| AUTL Autolus Therapeutics PLC | 350,525,000.0 | 476,965,000.0 |
| TWST Twist Bioscience Corp | 141,634,000.0 | 472,689,000.0 |
| ALLO Allogene Therapeutics Inc | 125,372,000.0 | 463,748,000.0 |
| AVIR Atea Pharmaceuticals Inc | 32,436,000.0 | 458,521,000.0 |
| HALO Halozyme Therapeutics Inc | 1,665,327,000.0 | 452,703,000.0 |
| ERAS Erasca Inc | 78,854,000.0 | 450,042,000.0 |
| IMVT Immunovant Inc | 66,653,000.0 | 449,054,000.0 |
| CSTL Castle Biosciences Inc | 73,510,000.0 | 441,055,000.0 |
| KNSA Kiniksa Pharmaceuticals International PLC | 118,292,000.0 | 437,006,000.0 |
| NKTX Nkarta Inc | 101,161,000.0 | 430,873,000.0 |
| ANIP ANI Pharmaceuticals Inc | 856,579,000.0 | 430,798,000.0 |
| IMTX Immatics NV | 216,765,356.03 | 425,862,370.54 |
| KURA Kura Oncology Inc | 55,066,000.0 | 423,771,000.0 |
| TRDA Entrada Therapeutics Inc | 132,143,000.0 | 422,447,000.0 |
| CTKB Cytek Biosciences Inc | 105,763,000.0 | 385,463,000.0 |
| PRAX Praxis Precision Medicines Inc | 33,590,000.0 | 382,666,000.0 |
| REPL Replimune Group Inc | 116,743,000.0 | 381,459,000.0 |
| ETNB 89Bio Inc | 80,195,000.0 | 378,102,000.0 |
| NRIX Nurix Therapeutics Inc | 136,744,000.0 | 376,856,000.0 |
| ZYME Zymeworks Inc | 120,174,000.0 | 366,978,000.0 |
| SNDX Syndax Pharmaceuticals Inc | 59,379,000.0 | 366,432,000.0 |
| TERN Terns Pharmaceuticals Inc | 13,763,000.0 | 364,470,000.0 |
| FATE Fate Therapeutics Inc | 132,644,000.0 | 362,326,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例